Home › Burkitt Lymphoma › Pennsylvania › Philadelphia

Pag-aaral pangklinika para sa Burkitt Lymphoma sa Philadelphia, PA

16 pag-aaral para sa Burkitt Lymphoma ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Philadelphia (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic Leukemia

Nagre-recruitPhase 3

Children's Hospital of Philadelphia (Data Collection Only), Philadelphia

Edad 1 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT07223021

A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)

Nagre-recruitPhase 1

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 18 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06173518

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia
Saint Christopher's Hospital for Children, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo

366 Days – 46 Years · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06124157

Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia

Nagre-recruitPhase 3

University of Pennsylvania/Abramson Cancer Center, Philadelphia
Thomas Jefferson University Hospital, Philadelphia

Edad 18 hanggang 39 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT03150693

Blinatumomab Consolidation in Real World

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

University of Pennsylvania, Philadelphia

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07117136

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

Nagre-recruitObservasyonal na pag-aaral

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 38 · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06131801

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo

365 Days · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia

6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia
Saint Christopher's Hospital for Children, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo

Edad 1 hanggang 30 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

Nagre-recruitPhase 3

Children's Hospital of Philadelphia, Philadelphia
Saint Christopher's Hospital for Children, Philadelphia
Alfred I duPont Hospital for Children, Wilmington · 25 mi ang layo

365 Days – 25 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03959085

Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL

Nagre-recruitPhase 2

Children's Hospital of Philadelphia, Philadelphia

Edad 7 hanggang 25 · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT05082519

CD45RA Depleted Peripheral Stem Cell Addback for Viral or Fungal Infections Post TCRαβ/CD19 Depleted HSCT

Nagre-recruit

Children's Hospital of Philadelphia, Philadelphia

Hanggang edad 25 · Lahat ng kasarian · Na-update Hul 8, 2026 · NCT03810196

Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia, Philadelphia

Edad 0 hanggang 29 · Lahat ng kasarian · Na-update May 26, 2026 · NCT05480449

Co-administration of CART22-65s and huCART19 for B-ALL

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia, Philadelphia

Hanggang edad 29 · Lahat ng kasarian · Na-update Mar 27, 2026 · NCT05674175

Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)

Nagre-recruitPhase 1/2

Children's Hospital of Philadelphia, Philadelphia

Edad 15 hanggang 50 · Lahat ng kasarian · Na-update Set 9, 2025 · NCT04150497

The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

Nagre-recruitPhase 2

Alfred I. duPont Hospital for Children - Nemours Deleware, Wilmington · 25 mi ang layo

Edad 1 hanggang 25 · Lahat ng kasarian · Na-update May 4, 2025 · NCT03509961

Pag-aaral para sa Burkitt Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Philadelphia

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.